润达医疗股价涨5.25%，东财基金旗下1只基金重仓，持有5.98万股浮盈赚取5.02万元

Group 1 - The core viewpoint of the news is that RunDa Medical has seen a stock price increase of 5.25%, reaching 16.85 CNY per share, with a total market capitalization of 10.172 billion CNY [1] - RunDa Medical, established on January 6, 1999, and listed on May 27, 2015, specializes in providing in vitro diagnostic products and professional technical support to various medical laboratories through its comprehensive service system [1] - The revenue composition of RunDa Medical includes 93.50% from reagents and other consumables, 3.70% from instruments, 2.67% from software development and services, and 0.14% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Dongcai has heavily invested in RunDa Medical, with the Dongcai Vision Growth Mixed Fund A (018088) increasing its holdings by 9,500 shares in the fourth quarter, making it the largest holding in the fund [2] - The Dongcai Vision Growth Mixed Fund A (018088) has a current scale of 10.8951 million CNY and has achieved a year-to-date return of 14.91%, ranking 432 out of 8,880 in its category [2] - The fund manager, Sun Chenyang, has been in position for 2 years and 307 days, with the best fund return during his tenure being 71.92% and the worst being -28.98% [3]